Human GBP1 does not localize to pathogen vacuoles but restricts Toxoplasma gondii

Cellular Microbiology

Volumn 18, Issue 8, 2016, Pages 1056-1064

  Johnston, Ashleigh C ^a   Piro, Anthony ^b   Clough, Barbara ^a   Siew, Malvin ^a   Virreira Winter, Sebastian ^c   Coers, Jörn ^b   Frickel, Eva Maria ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE BINDING PROTEIN 1; GUANYLATE BINDING PROTEIN 2; INFLAMMASOME; UNCLASSIFIED DRUG; GBP1 PROTEIN, HUMAN;

ARTICLE; CELL VACUOLE; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; HOST RESISTANCE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TOXOPLASMA GONDII; A-549 CELL LINE; EPITHELIUM CELL; METABOLISM; MICROBIOLOGY; PARASITOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; TOXOPLASMA;

A549 CELLS; CHLAMYDIA TRACHOMATIS; EPITHELIAL CELLS; GTP-BINDING PROTEINS; HUMANS; PROTEIN TRANSPORT; SALMONELLA TYPHIMURIUM; TOXOPLASMA; VACUOLES;

EID: 84960155025     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12579     Document Type: Article

References (33)

1. Al-Zeer, M.A., Al-Younes, H.M., Lauster, D., Abu Lubad, M., and Meyer, T.F. (2013) Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins. Autophagy 9: 50–62.
2. Anderson, S.L., Carton, J.M., Lou, J., Xing, L., and Rubin, B.Y. (1999) Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256: 8–14.
3. Cheng, Y.S., Colonno, R.J., and Yin, F.H. (1983) Interferon induction of fibroblast proteins with guanylate binding activity. J Biol Chem 258: 7746–50.
4. Coers, J., Bernstein-Hanley, I., Grotsky, D., Parvanova, I., Howard, J.C., Taylor, G.A., et al. (2008) Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J Immunol 180: 6237–45.
5. Degrandi, D., Konermann, C., Beuter-Gunia, C., Kresse, A., Wurthner, J., Kurig, S., et al. (2007) Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J Immunol 179: 7729–40.
6. Finethy, R., Jorgensen, I., Haldar, A.K., De Zoete, M.R., Strowig, T., Flavell, R.A., et al. (2015) Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages. Infect Immun 83: 4740–9.
7. Guenzi, E., Topolt, K., Cornali, E., Lubeseder-Martellato, C., Jorg, A., Matzen, K., et al. (2001) The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J 20: 5568–77.
8. Haldar, A.K., Foltz, C., Finethy, R., Piro, A.S., Feeley, E.M., Pilla-Moffett, D.M., et al. (2015) Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins. Proc Natl Acad Sci U S A 112: E5628–37.
9. Haldar, A.K., Saka, H.A., Piro, A.S., Dunn, J.D., Henry, S.C., Taylor, G.A., et al. (2013) IRG and GBP host resistance factors target aberrant, “non-self” vacuoles characterized by the missing of “self” IRGM proteins. PLoS Pathog 9: e1003414.
10. Kazar, J., Gillmore, J.D., and Gordon, F.B. (1971) Effect of interferon and interferon inducers on infections with a nonviral intracellular microorganism, Chlamydia trachomatis. Infect Immun 3: 825–32.
11. Kim, B.H., Shenoy, A.R., Kumar, P., Das, R., Tiwari, S., and Macmicking, J.D. (2011) A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Science 332: 717–21.
12. Ling, Y.M., Shaw, M.H., Ayala, C., Coppens, I., Taylor, G.A., Ferguson, D.J., and Yap, G.S. (2006) Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J Exp Med 203: 2063–71.
13. Macmicking, J.D. (2012) Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 12: 367–82.
14. Man, S.M., Karki, R., Malireddi, R.K., Neale, G., Vogel, P., Yamamoto, M., et al. (2015) The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat Immunol 16: 467–75.
15. Martens, S., Parvanova, I., Zerrahn, J., Griffiths, G., Schell, G., Reichmann, G., and Howard, J.C. (2005) Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog 1: e24.
16. Meunier, E., Dick, M.S., Dreier, R.F., Schurmann, N., Kenzelmann Broz, D., Warming, S., et al. (2014) Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature 509: 366–70.
17. Meunier, E., Wallet, P., Dreier, R.F., Costanzo, S., Anton, L., Ruhl, S., et al. (2015) Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida. Nat Immunol 16: 476–84.
18. Ohshima, J., Lee, Y., Sasai, M., Saitoh, T., Su ma, J., Kamiyama, N., et al. (2014) Role of mouse and human autophagy proteins in IFN-gamma-induced cell-autonomous responses against Toxoplasma gondii. J Immunol 192: 3328–35.
19. Pan, W., Zuo, X., Feng, T., Shi, X., and Dai, J. (2012) Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus. Virol J 9: 292.
20. Perrin, A.J., Jiang, X., Birmingham, C.L., So, N.S., and Brumell, J.H. (2004) Recognition of bacteria in the cytosol of mammalian cells by the ubiquitin system. Curr Biol 14: 806–11.
21. Pie, S., Truffa-Bachi, P., Pla, M., and Nauciel, C. (1997) Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance. Infect Immun 65: 4509–14.
22. Pilla, D.M., Hagar, J.A., Haldar, A.K., Mason, A.K., Degrandi, D., Pfeffer, K., et al. (2014) Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. Proc Natl Acad Sci U S A 111: 6046–51.
23. Prakash, B., Praefcke, G.J., Renault, L., Wittinghofer, A., and Herrmann, C. (2000) Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403: 567–71.
24. Ran et al. 2013. PMID 24157548.
25. Saka, H.A., Thompson, J.W., Chen, Y.S., Kumar, Y., Dubois, L.G., Moseley, M.A., and Valdivia, R.H. (2011) Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms. Mol Microbiol 82: 1185–203.
26. Schwemmle, M., and Staeheli, P. (1994) The interferon-induced 67-kDa guanylate-binding protein (hGBP1) is a GTPase that converts GTP to GMP. J Biol Chem 269: 11299–305.
27. Selleck, E.M., Fentress, S.J., Beatty, W.L., Degrandi, D., Pfeffer, K., Virgin, H.W.T., et al. (2013) Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog 9: e1003320.
28. Shenoy, A.R., Wellington, D.A., Kumar, P., Kassa, H., Booth, C.J., Cresswell, P., and Macmicking, J.D. (2012) GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 336: 481–5.
29. Syguda, A., Bauer, M., Benscheid, U., Ostler, N., Naschberger, E., Ince, S., et al. (2012) Tetramerization of human guanylate-binding protein 1 is mediated by coiled-coil formation of the C-terminal alpha-helices. FEBS J 279: 2544–54.
30. Thurston, T.L., Wandel, M.P., Von Muhlinen, N., Foeglein, A., and Randow, F. (2012) Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482: 414–8.
31. Tietzel, I., El-Haibi, C., and Carabeo, R.A. (2009) Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma. PLoS One 4: e6499.
32. Virreira Winter, S., Niedelman, W., Jensen, K.D., Rosowski, E.E., Julien, L., Spooner, E., et al. (2011) Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it. PLoS One 6: e24434.
33. Wang, Y., Kahane, S., Cutcliffe, L.T., Skilton, R.J., Lambden, P.R., and Clarke, I.N. (2011) Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog 7: e1002258.